THOMPSON DAVIS & CO., INC. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 143 filers reported holding IMMUNOGEN INC in Q2 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2017$1,000
-50.0%
139
-60.1%
0.00%
-33.3%
Q2 2017$2,000
+100.0%
3480.0%0.00%
+200.0%
Q1 2017$1,0000.0%3480.0%0.00%
-50.0%
Q4 2016$1,0000.0%3480.0%0.00%0.0%
Q3 2016$1,0000.0%3480.0%0.00%0.0%
Q2 2016$1,000
-66.7%
3480.0%0.00%
-50.0%
Q1 2016$3,000
-40.0%
3480.0%0.00%
-42.9%
Q4 2015$5,000
+66.7%
3480.0%0.01%
+75.0%
Q3 2015$3,000
-40.0%
3480.0%0.00%
-33.3%
Q2 2015$5,000
+66.7%
3480.0%0.01%
+50.0%
Q1 2015$3,000
+50.0%
3480.0%0.00%
+100.0%
Q4 2014$2,0003480.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2015
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders